Transdiagnostic Behavioral Therapy for Anxiety and Depression in Autistic Adolescents
Anxiety, Depression, Emotional Disorder
About this trial
This is an interventional treatment trial for Anxiety focused on measuring Cognitive behavioral therapy, CBT, exposure therapy, behavioral activation
Eligibility Criteria
Inclusion Criteria: Child is between the ages of 12-17 at consent/assent. The child meets criteria for autism spectrum disorder using evidence-based assessment approaches (e.g., Autism Diagnostic Observation Schedule-Second Edition; Childhood Autism Rating Scale-Second Edition). The child meets criteria for clinically significant anxiety and/or depression symptoms based on elevated scores on the Pediatric Anxiety Rating Scale modified for Autism Spectrum Disorder (>11) and/or the Children's Depression Rating Scale-Revised (>39). Anxiety/depressive disorder is the primary presenting problem as determined by administration of the Mini International Neuropsychiatric Interview One parent/guardian is able and willing to participate. The parent/guardian is 18 years or older. Both parent and child can read and/or understand English. Both parent and child reside in Texas. Exclusion Criteria: The child has a diagnosis of psychotic disorder and/or conduct disorder. The child has severe suicidal/homicidal ideation and/or self-injury requiring immediate intervention and/or a higher level of care. The child has limited verbal communication abilities. The child is receiving concurrent psychotherapy for anxiety/depression. The child has initiated psychotropic medications within 12 weeks of assessments (or 4 weeks for stimulants/benzodiazepines) or during therapy, and/or has changed dosage of psychotropic medication within 6 weeks of assessment (or 2 weeks for stimulants/benzodiazepines) or during therapy.
Sites / Locations
- Baylor Psychiatry ClinicRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Transdiagnostic cognitive behavioral therapy
Treatment as usual